Caveolar endocytosis is an important mechanism for the uptake of certain pathogens and toxins and also plays a role in the internalization of some plasma membrane (PM) lipids and proteins. However, the regulation of caveolar endocytosis is not well understood. We previously demonstrated that caveolar endocytosis and β1-integrin signaling are stimulated by exogenous glycosphingolipids (GSLs). In this study, we show that a synthetic GSL with nonnatural stereochemistry, β-d-lactosyl-N-octanoyl-l-threo-sphingosine, (1) selectively inhibits caveolar endocytosis and SV40 virus infection, (2) blocks the clustering of lipids and proteins into GSLs and cholesterol-enriched microdomains (rafts) at the PM, and (3) inhibits β1-integrin activation and downstream signaling. Finally, we show that small interfering RNA knockdown of β1 integrin in human skin fibroblasts blocks caveolar endocytosis and the stimulation of signaling by a GSL with natural stereochemistry. These experiments identify a new compound that can interfere with biological processes by inhibiting microdomain formation and also identify β1 integrin as a potential mediator of signaling by GSLs.
Skip Nav Destination
Article navigation
26 March 2007
Report|
March 19 2007
Inhibition of caveolar uptake, SV40 infection, and β1-integrin signaling by a nonnatural glycosphingolipid stereoisomer
Raman Deep Singh,
Raman Deep Singh
1Department of Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, MN 55905
Search for other works by this author on:
Eileen L. Holicky,
Eileen L. Holicky
1Department of Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, MN 55905
Search for other works by this author on:
Zhi-jie Cheng,
Zhi-jie Cheng
1Department of Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, MN 55905
Search for other works by this author on:
Seong-Youl Kim,
Seong-Youl Kim
1Department of Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, MN 55905
Search for other works by this author on:
Christine L. Wheatley,
Christine L. Wheatley
1Department of Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, MN 55905
Search for other works by this author on:
David L. Marks,
David L. Marks
1Department of Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, MN 55905
Search for other works by this author on:
Robert Bittman,
Robert Bittman
2Department of Chemistry and Biochemistry, Queens College, The City University of New York, Flushing, NY 11367
Search for other works by this author on:
Richard E. Pagano
Richard E. Pagano
1Department of Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, MN 55905
Search for other works by this author on:
Raman Deep Singh
1Department of Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, MN 55905
Eileen L. Holicky
1Department of Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, MN 55905
Zhi-jie Cheng
1Department of Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, MN 55905
Seong-Youl Kim
1Department of Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, MN 55905
Christine L. Wheatley
1Department of Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, MN 55905
David L. Marks
1Department of Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, MN 55905
Robert Bittman
2Department of Chemistry and Biochemistry, Queens College, The City University of New York, Flushing, NY 11367
Richard E. Pagano
1Department of Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, MN 55905
Correspondence to Richard E. Pagano: [email protected]
Abbreviations used in this paper: Ab, antibody; β1-stim Ab, stimulatory β1-integrin Ab; CtxB, cholera toxin B; GPI, glycosyl-phosphatidylinositol; GSL, glycosphingolipid; HSF, human skin fibroblast; IL-2R, interleukin-2 receptor β subunit; LacCer, lactosylceramide; PM, plasma membrane; Tfn, transferrin.
Received:
September 25 2006
Accepted:
February 16 2007
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2007
J Cell Biol (2007) 176 (7): 895–901.
Article history
Received:
September 25 2006
Accepted:
February 16 2007
Citation
Raman Deep Singh, Eileen L. Holicky, Zhi-jie Cheng, Seong-Youl Kim, Christine L. Wheatley, David L. Marks, Robert Bittman, Richard E. Pagano; Inhibition of caveolar uptake, SV40 infection, and β1-integrin signaling by a nonnatural glycosphingolipid stereoisomer . J Cell Biol 26 March 2007; 176 (7): 895–901. doi: https://doi.org/10.1083/jcb.200609149
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement